Glycomimetics(GLYC)

超过5%股东持股披露「修订」

Glycomimetics(GLYC)03-01 08:35

$Glycomimetics(GLYC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-24-000287  Act: 34  Size: 350 KB 网页链接查看全文

其他

Glycomimetics(GLYC)03-23 05:05

$Glycomimetics(GLYC)$ PRE 14A Other preliminary proxy statements Accession Number: 0001558370-24-003788  Act: 34  Size: 1 MB 网页链接查看全文

超过5%股东持股披露「修订」

Glycomimetics(GLYC)02-13 05:55

$Glycomimetics(GLYC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-24-000125  Act: 34  Size: 346 KB 网页链接查看全文

超过5%股东持股披露「修订」

Glycomimetics(GLYC)01-30 05:35

$Glycomimetics(GLYC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-000153  Act: 34  Size: 277 KB 网页链接查看全文

员工持股计划

Glycomimetics(GLYC)03-28 04:05

$Glycomimetics(GLYC)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001558370-24-004078  Act: 33  Size: 178 KB 网页链接查看全文

美股滚雪球03-27 22:01

$Glycomimetics(GLYC)$ 在二季度发布 Topline data from pivotal Phase 3 study of Uproleselan in relapsed/refractory (R/R) AML，对股价影响很大。$传奇生物(LEGN)$ $美团-W(03690)$查看全文

股东委托书协议

Glycomimetics(GLYC)04-01 20:35

$Glycomimetics(GLYC)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-004448  Act: 34  Size: 1 MB 网页链接查看全文

当期报告

Glycomimetics(GLYC)03-01 22:25

$Glycomimetics(GLYC)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-24-002241  Act: 34  Size: 7 MB 网页链接查看全文

年度财报

Glycomimetics(GLYC)03-27 20:35

$Glycomimetics(GLYC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-004013  Act: 34  Size: 7 MB 网页链接查看全文

其他

Glycomimetics(GLYC)04-01 20:35

$Glycomimetics(GLYC)$ ARS Annual Report to Security Holders Accession Number: 0001558370-24-004451  Act: 34  Size: 4 MB 网页链接查看全文

持股变动声明

$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009744  Size: 5 KB 网页链接

持股变动声明

$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009743  Size: 7 KB 网页链接

持股变动声明

$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009745  Size: 4 KB 网页链接

股东委托书协议

$Glycomimetics(GLYC)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-004448  Act: 34  Size: 1 MB 网页链接

其他

$Glycomimetics(GLYC)$ ARS Annual Report to Security Holders Accession Number: 0001558370-24-004451  Act: 34  Size: 4 MB 网页链接

员工持股计划

$Glycomimetics(GLYC)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001558370-24-004078  Act: 33  Size: 178 KB 网页链接

当期报告

$Glycomimetics(GLYC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-004015  Act: 34  Size: 427 KB 网页链接

年度财报

$Glycomimetics(GLYC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-004013  Act: 34  Size: 7 MB 网页链接

其他

$Glycomimetics(GLYC)$ PRE 14A Other preliminary proxy statements Accession Number: 0001558370-24-003788  Act: 34  Size: 1 MB 网页链接

当期报告

$Glycomimetics(GLYC)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-24-002241  Act: 34  Size: 7 MB 网页链接